Helsinn Group Welcomes New Board Member
Meet Riccardo Carbucicchio
Helsinn Group, a leader in the global pharmaceutical industry, has made a significant appointment by adding Riccardo Carbucicchio to its Board of Directors. This move highlights a strong commitment to enhancing leadership and aims to stimulate innovation and performance within the pharmaceutical sector.
Bringing Valuable Expertise
Riccardo Carbucicchio comes with a rich background in pharmaceutical management. Currently, he holds the position of Chief Executive Officer at NTC Pharma, where his leadership has been pivotal in steering the company toward its strategic goals. His extensive knowledge in pharmaceuticals is further underscored by his previous positions at well-respected organizations.
Career Achievements
Before his current role, Carbucicchio made significant contributions at Novartis, serving as the Head of Partnering for General Medicines and Mature Products. His experience also includes being the Managing Director for Bausch + Lomb Italy, where he effectively led operations across various countries, improving both performance and market presence.
Carbucicchio's Vision for Helsinn
In this new capacity, Carbucicchio is ready to make a substantial impact on Helsinn’s mission to enhance the quality of life for patients. Existing board members have welcomed his appointment with enthusiasm, particularly Executive Chairman Riccardo Braglia.
Leadership Insights
Braglia shared his optimism regarding Carbucicchio's abilities, expressing, “I am delighted to welcome Riccardo to Helsinn's Board of Directors and look forward to his contribution. His extensive expertise will provide invaluable insights into the challenges and opportunities that await Helsinn.” This statement showcases Helsinn's strategic approach as it tackles the complexities inherent in today’s healthcare landscape.
A Common Commitment
Reflecting on his new position, Carbucicchio remarked, “Helsinn has an outstanding reputation in the industry, known for its collaborative approach and dedication to improving patient care. I share this commitment and am eager to collaborate with the Board to advance this important mission.” His excitement resonates with Helsinn's core values, which prioritize patient well-being and innovative healthcare solutions.
About Helsinn Group
Established in 1976, Helsinn Group has earned its place as an innovator in the pharmaceutical sector, concentrating on supportive care, oncology, and dermato-oncology. As a third-generation family business, it is fueled by integrity and a determination for quality. The company is committed to ongoing innovation and sustainable growth, which remains central to its business strategy.
Headquartered in Lugano, Switzerland, Helsinn has a direct presence in the United States and maintains a significant network of partnerships that spans over 90 countries. The organization is dedicated to improving the quality of life for patients dealing with cancer and chronic conditions.
Commitment to Progress
Helsinn’s focus on effective solutions is evident in its ongoing investments in research and development. The company aims to create impactful therapies that meet the needs of patients around the world. As Helsinn advances, it’s not just about maintaining high standards in pharmaceuticals; it’s also about making meaningful progress that serves society as a whole.
Frequently Asked Questions
Who is Riccardo Carbucicchio?
Riccardo Carbucicchio is the newest member of the Helsinn Group Board of Directors, bringing a wealth of experience in pharmaceutical management.
What is Helsinn Group's focus?
Helsinn Group specializes in supportive care, oncology, and dermato-oncology, all aimed at improving patients' quality of life.
What roles did Carbucicchio have before joining Helsinn?
He has held significant roles as CEO of NTC Pharma, along with key positions at Novartis and Bausch + Lomb.
What did Helsinn officials say about Carbucicchio's appointment?
Executive Chairman Riccardo Braglia voiced confidence in Carbucicchio's expertise and enthusiasm for the exciting opportunities to come.
Where is Helsinn headquartered?
Helsinn Group is based in Lugano, Switzerland, with operations throughout the United States and partnered with various global entities.
